Humana ABLTS:0RF7 +3.44%67 FCF Margin % is 2.70% as of Mar. 2026, which is 59% below its 10-year median of 6.62. GuruFocus rates LTS:0RF7 with a GF Score™ of 67/100 and a GF Value™ of kr36.46 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Humana AB ranks better than 63.08% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Humana AB's Free Cash Flow for the
three
months ended in Mar. 2026 was kr67 Mil. Humana AB's Revenue for the
three
months ended in Mar. 2026 was kr2,479 Mil. Therefore, Humana AB's FCF Margin % for the quarter that ended in Mar. 2026 was 2.70%.
The historical rank and industry rank for Humana AB's FCF Margin % or its related term are showing as below:
LTS:0RF7'
s FCF Margin % Range Over the Past 10 Years
Min: -4.78 Med: 6.62 Max: 8.44
Current: 7.23
During the past 13 years, the highest FCF Margin % of Humana AB was 8.44%. The lowest was -4.78%. And the median was 6.62%.
LTS:0RF7's FCF Margin % is ranked better than 63.08% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 3.39
vs LTS:0RF7: 7.23
Humana AB FCF Margin % Related Terms
Humana AB FCF Margin % Historical Data
* Premium members only.
The historical data trend for Humana AB's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0RF7 vs HCA, THC, DVA: FCF Margin % Comparison
For the Medical Care Facilities subindustry, Humana AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Humana AB FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Humana AB's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Humana AB's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Humana AB (LTS:0RF7) has a FCF Margin % of 2.70% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Humana AB and its competitors. This is 59% below median its historical median of 6.62. According to the industry distribution chart, Humana AB ranks #247 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 36.9%.
Is Humana AB's FCF Margin % too high?
Humana AB's current FCF Margin % of 2.70% is 59% below median its 10-year median of 6.62. The Healthcare Providers & Services industry median FCF Margin % is 3.39. Humana AB's value of 2.70% is 20.4% below this industry median. Based on the distribution chart, Humana AB ranks #247 out of 669 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Humana AB has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Humana AB's FCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Humana AB ranks #247 out of 669 companies for FCF Margin %. This puts Humana AB in the upper half of its industry. The industry median FCF Margin % is 3.39. Humana AB's value of 2.70% is 20.4% below this benchmark. While the company's 10-year median is 6.62 vs. the industry median of 3.39, Humana AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.39, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Humana AB's current FCF Margin % of 2.70% is 20.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Humana AB and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Humana AB's current FCF Margin % is 2.70%, which is 59% below median its own 10-year median of 6.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humana AB stock overvalued right now?
Based on GuruFocus' analysis, Humana AB (LTS:0RF7) is currently considered Significantly Overvalued. The stock's GF Value™ is kr36.46, compared to a current price of kr48.13 — trading 32% above its estimated fair value. The current FCF Margin % is 2.70%, which is 59% below median its 10-year median of 6.62 and 20.4% below the Healthcare Providers & Services industry median of 3.39. Humana AB's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Humana AB (LTS:0RF7), the current FCF Margin % is 2.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Humana AB (LTS:0RF7) Overvalued in 2026?
Based on GuruFocus' analysis, Humana AB stock appears to be overvalued.
The current stock price of kr48.13 is trading 32% above its estimated GF Value™ of kr36.46.
GuruFocus considers Humana AB to be Significantly Overvalued.
Key valuation signals for LTS:0RF7:
FCF Margin %: 2.70% (59% below median its 10-year median of 6.62)
GF Value™: kr36.46 vs. price of kr48.13 (32% above fair value)
Industry Position: 20.4% below the Healthcare Providers & Services median (#247 of 669)
No single metric tells the full story. See the LTS:0RF7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Humana AB is a provider of private care services in the Nordic region. The company offers services including individual and family care, personal assistance, elderly care and housing with special services. Geographically, the company operates in Sweden, Norway, Finland, Denmark, and others. It derives maximum revenue from Sweden.
67GF Score
Get the complete analysis for LTS:0RF7
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RF7 has been successfully added to your 
